Quantification of the completeness of follow-up

被引:346
作者
Clark, TG [1 ]
Altman, DG
De Stavola, BL
机构
[1] Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England
[2] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London W1CE 7HT, England
关键词
D O I
10.1016/S0140-6736(02)08272-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Completeness of follow-up is important, especially In clinical trials, since unequal follow-up In the treatment groups can bias the analysis of results. In survival studies, information on participants who do not complete the study is often omitted because their data can be Included up to the time at which they were lost to follow-up. We propose a simple measure of completeness that Is the ratio of the total observed person-time and the potential person-time of follow-up in a study. Our measure is easy to calculate, can be Illustrated pictorially, and can be used to Identify subgroups with especially poor follow-up.
引用
收藏
页码:1309 / 1310
页数:2
相关论文
共 5 条
[1]   BENEFICIAL EFFECT OF AZATHIOPRINE AND PREDICTION OF PROGNOSIS IN PRIMARY BILIARY-CIRRHOSIS - FINAL RESULTS OF AN INTERNATIONAL TRIAL [J].
CHRISTENSEN, E ;
NEUBERGER, J ;
CROWE, J ;
ALTMAN, DG ;
POPPER, H ;
PORTMANN, B ;
DONIACH, D ;
RANEK, L ;
TYGSTRUP, N ;
WILLIAMS, R .
GASTROENTEROLOGY, 1985, 89 (05) :1084-1091
[2]   A prognostic model for ovarian cancer [J].
Clark, TG ;
Stewart, ME ;
Altman, DG ;
Gabra, H ;
Smyth, JF .
BRITISH JOURNAL OF CANCER, 2001, 85 (07) :944-952
[3]   LONG-TERM PROGNOSTIC VALUE OF SERUM-BETA-2 MICROGLOBULIN IN MYELOMATOSIS [J].
CUZICK, J ;
DESTAVOLA, BL ;
COOPER, EH ;
CHAPMAN, C ;
MACLENNAN, ICM .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (04) :506-510
[4]   The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials [J].
Moher, D ;
Schulz, KF ;
Altman, DG .
LANCET, 2001, 357 (9263) :1191-1194
[5]   A note on quantifying follow-up in studies of failure time [J].
Schemper, M ;
Smith, TL .
CONTROLLED CLINICAL TRIALS, 1996, 17 (04) :343-346